Spontaneous adverse drug reaction monitoring in oncology: Our experience.
Kaur, Kirandeep; Sood, Megha; Bhagat, Shivani; Singh, Tarundeep; Jain, Mukta; Arora, Deepty; Sekhon, J S; Kaushal, Sandeep.
Indian J Cancer
; 2015 July-Sept; 52(3): 467-470
Artículo en Inglés | IMSEAR | ID: sea-173980
Documentos relacionados
Spontaneous adverse drug reaction monitoring in oncology: Our experience.
[Modern anticoagulation with factor Xa inhibitors in oncology: is the gastrointestinal bleeding rate (also) decisive?]
[Shock wave therapy in oncology: in vitro, in vivo, rehabilitation].
[Mindfulness and Skills Based Distress Reduction in Oncology: The Web-Based Psycho-Oncological Make It Training].
Overview of premedication prescription and intake in an oncology day hospital: What do we need to change to improve patient management?
[The COVID-pandemic and specialist training in Head and Neck oncology: A Survey among Physicians].
[Da vinci robotic surgery in gynaecological oncology: a critical interim appraisal].
[Pain therapy in oncology: results of a nationwide survey].
[The first 25 years of oncopsychology at the National Institute of Oncology: antecedents and events (1988-2013)].
[Vitamin D in oncology: Update 2015].